Role of autophagy in the host response to microbial infection and potential for therapy

Current Opinion in Immunology

Volumn 23, Issue 1, 2011, Pages 65-70

  Fabri, Mario ^a,b   Realegeno, Susan E ^a   Jo, Eun Kyeong ^c   Modlin, Robert L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF COLOGNE   (Germany)

^c Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CALCITRIOL; CD40 LIGAND; CELECOXIB; GAMMA INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE COFACTOR PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; POLYPEPTIDE ANTIBIOTIC AGENT; RESVERATROL; TOLL LIKE RECEPTOR;

ANTIBACTERIAL ACTIVITY; ANTIVIRAL ACTIVITY; AUTOPHAGY; BACTERIAL INFECTION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; FRANCISELLA TULARENSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOMODULATION; INFLUENZA A; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SALMONELLA ENTERICA; SALMONELLA TYPHIMURIUM; T LYMPHOCYTE; TUBERCULOSIS; UBIQUITINATION; VACCINATION; VIRUS INFECTION; VITAMIN SUPPLEMENTATION;

ADAPTIVE IMMUNITY; ANIMALS; AUTOPHAGY; BACTERIAL INFECTIONS; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION;

EID: 79951672349     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.10.010     Document Type: Review

References (59)

1. Sibley L.D., Weidner E., Krahenbuhl J.L. Phagosome acidification blocked by intracellular Toxoplasma gondii. Nature 1985, 315:416-419.
2. Armstrong J.A., Hart P.D. Response of cultured macrophages to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J Exp Med 1971, 134:713-740.
3. de Chastellier C., Berche P. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect Immun 1994, 62:543-553.
4. Zychlinsky A., Prevost M.C., Sansonetti P.J. Shigella flexneri induces apoptosis in infected macrophages. Nature 1992, 358:167-169.
5. Deretic V., Levine B. Autophagy, immunity, and microbial adaptations. Cell Host Microbe 2009, 5:527-549.
6. Nedjic J., Aichinger M., Emmerich J., Mizushima N., Klein L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 2008, 455:396-400.
7. Munz C. Antigen processing via autophagy-not only for MHC class II presentation anymore?. Curr Opin Immunol 2010, 22:89-93.
8. Ogawa M., Sasakawa C. Bacterial evasion of the autophagic defense system. Curr Opin Microbiol 2006, 9:62-68.
9. Schnaith A., Kashkar H., Leggio S.A., Addicks K., Kronke M., Krut O. Staphylococcus aureus subvert autophagy for induction of caspase-independent host cell death. J Biol Chem 2007, 282:2695-2706.
10. Lee H.K., Lund J.M., Ramanathan B., Mizushima N., Iwasaki A. Autophagy-dependent viral recognition by plasmacytoid dendritic cells. Science 2007, 315:1398-1401.
11. Tal M.C., Sasai M., Lee H.K., Yordy B., Shadel G.S., Iwasaki A. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 2009, 106:2770-2775.
12. Sumpter R., Levine B. Autophagy and innate immunity: triggering, targeting and tuning. Semin Cell Dev Biol 2010, 21:699-711.
13. Xu Y., Jagannath C., Liu X.D., Sharafkhaneh A., Kolodziejska K.E., Eissa N.T. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 2007, 27:135-144.
14. Delgado M.A., Elmaoued R.A., Davis A.S., Kyei G., Deretic V. Toll-like receptors control autophagy. EMBO J 2008, 27:1110-1121.
15. Shin D.M., Yuk J.M., Lee H.M., Lee S.H., Son J.W., Harding C.V., Kim J.M., Modlin R.L., Jo E.K. Mycobacterial lipoprotein activates autophagy via TLR2/1/CD14 and a functional vitamin D receptor signaling. Cell Microbiol 2010.
16. Cooney R., Baker J., Brain O., Danis B., Pichulik T., Allan P., Ferguson D.J., Campbell B.J., Jewell D., Simmons A. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010, 16:90-97.
17. Travassos L.H., Carneiro L.A., Ramjeet M., Hussey S., Kim Y.G., Magalhaes J.G., Yuan L., Soares F., Chea E., Le Bourhis L., et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010, 11:55-62.
18. Sanjuan M.A., Dillon C.P., Tait S.W., Moshiach S., Dorsey F., Connell S., Komatsu M., Tanaka K., Cleveland J.L., Withoff S., et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 2007, 450:1253-1257.
19. Saitoh T., Fujita N., Jang M.H., Uematsu S., Yang B.G., Satoh T., Omori H., Noda T., Yamamoto N., Komatsu M., et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 2008, 456:264-268.
20. Meiffren G., Joubert P.E., Gregoire I.P., Codogno P., Rabourdin-Combe C., Faure M. Pathogen recognition by the cell surface receptor CD46 induces autophagy. Autophagy 2010, 6:299-300.
21. Andrade R.M., Wessendarp M., Gubbels M.J., Striepen B., Subauste C.S. CD40 induces macrophage anti-Toxoplasma gondii activity by triggering autophagy-dependent fusion of pathogen-containing vacuoles and lysosomes. J Clin Invest 2006, 116:2366-2377.
22. Harris J., De Haro S.A., Master S.S., Keane J., Roberts E.A., Delgado M., Deretic V. T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. Immunity 2007, 27:505-517.
23. Gutierrez M.G., Master S.S., Singh S.B., Taylor G.A., Colombo M.I., Deretic V. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 2004, 119:753-766.
24. Singh S.B., Davis A.S., Taylor G.A., Deretic V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 2006, 313:1438-1441.
25. Tiwari S., Choi H.P., Matsuzawa T., Pypaert M., MacMicking J.D. Targeting of the GTPase Irgm1 to the phagosomal membrane via PtdIns(3,4)P(2) and PtdIns(3,4,5)P(3) promotes immunity to mycobacteria. Nat Immunol 2009, 10:907-917.
26. Bekpen C., Hunn J.P., Rohde C., Parvanova I., Guethlein L., Dunn D.M., Glowalla E., Leptin M., Howard J.C. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol 2005, 6:R92.
27. Balgi A.D., Fonseca B.D., Donohue E., Tsang T.C., Lajoie P., Proud C.G., Nabi I.R., Roberge M. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS ONE 2009, 4:e7124.
28. Araki K., Youngblood B., Ahmed R. The role of mTOR in memory CD8 T-cell differentiation. Immunol Rev 2010, 235:234-243.
29. Subauste C.S. Autophagy as an antimicrobial strategy. Expert Rev Anti Infect Ther 2009, 7:743-752.
30. http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/021083s033,021110s043lbl.pdf.
31. Turcotte S., Giaccia A.J. Targeting cancer cells through autophagy for anticancer therapy. Curr Opin Cell Biol 2010, 22:246-251.
32. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., Larsen C.P., Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
33. Sarkar S., Perlstein E.O., Imarisio S., Pineau S., Cordenier A., Maglathlin R.L., Webster J.A., Lewis T.A., O'Kane C.J., Schreiber S.L., et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat Chem Biol 2007, 3:331-338.
34. Floto R.A., Sarkar S., Perlstein E.O., Kampmann B., Schreiber S.L., Rubinsztein D.C. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 2007, 3:620-622.
35. Chiu H.C., Soni S., Kulp S.K., Curry H., Wang D., Gunn J.S., Schlesinger L.S., Chen C.S. Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent. J Biomed Sci 2009, 16:110.
36. Chiu H.C., Kulp S.K., Soni S., Wang D., Gunn J.S., Schlesinger L.S., Chen C.S. Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent. Antimicrob Agents Chemother 2009, 53:5236-5244.
37. Hoyer-Hansen M., Bastholm L., Mathiasen I.S., Elling F., Jaattela M. Vitamin D analog EB1089 triggers dramatic lysosomal changes and Beclin 1-mediated autophagic cell death. Cell Death Differ 2005, 12:1297-1309.
38. Yuk J.M., Shin D.M., Lee H.M., Yang C.S., Jin H.S., Kim K.K., Lee Z.W., Lee S.H., Kim J.M., Jo E.K. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009, 6:231-243.
39. Bikle D.D. Vitamin D: newly discovered actions require reconsideration of physiologic requirements. Trends Endocrinol Metab 2010, 21:375-384.
40. Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
41. Liu P.T., Schenk M., Walker V.P., Dempsey P.W., Kanchanapoomi M., Wheelwright M., Vazirnia A., Zhang X., Steinmeyer A., Zugel U., et al. Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS ONE 2009, 4:e5810.
42. von Essen M.R., Kongsbak M., Schjerling P., Olgaard K., Odum N., Geisler C. Vitamin D controls T cell antigen receptor signaling and activation of human T cells. Nat Immunol 2010, 11:344-349.
43. Sato M., Lu J., Iturria S., Stayrook K.R., Burris L.L., Zeng Q.Q., Schmidt A., Barr R.J., Montrose-Rafizadeh C., Bryant H.U., et al. A nonsecosteroidal vitamin D receptor ligand with improved therapeutic window of bone efficacy over hypercalcemia. J Bone Miner Res 2010, 25:1326-1336.
44. Yamshchikov A.V., Desai N.S., Blumberg H.M., Ziegler T.R., Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009, 15:438-449.
45. Ponpuak M., Davis A.S., Roberts E.A., Delgado M.A., Dinkins C., Zhao Z., Virgin H.W.t., Kyei G.B., Johansen T., Vergne I., et al. Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010, 32:329-341.
46. Thurston T.L., Ryzhakov G., Bloor S., von Muhlinen N., Randow F. The TBK1 adaptor and autophagy receptor NDP52 restricts the proliferation of ubiquitin-coated bacteria. Nat Immunol 2009, 10:1215-1221.
47. Shahnazari S., Yen W.L., Birmingham C.L., Shiu J., Namolovan A., Zheng Y.T., Nakayama K., Klionsky D.J., Brumell J.H. A diacylglycerol-dependent signaling pathway contributes to regulation of antibacterial autophagy. Cell Host Microbe 2010, 8:137-146.
48. Wong E., Cuervo A.M. Autophagy gone awry in neurodegenerative diseases. Nat Neurosci 2010, 13:805-811.
49. Puissant A., Robert G., Auberger P. Targeting autophagy to fight hematopoietic malignancies. Cell Cycle 2010, 9.
50. Buzzai M., Jones R.G., Amaravadi R.K., Lum J.J., DeBerardinis R.J., Zhao F., Viollet B., Thompson C.B. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res 2007, 67:6745-6752.
51. Robert G., Ben Sahra I., Puissant A., Colosetti P., Belhacene N., Gounon P., Hofman P., Bost F., Cassuto J.P., Auberger P. Acadesine kills chronic myelogenous leukemia (CML) cells through PKC-dependent induction of autophagic cell death. PLoS ONE 2009, 4:e7889.
52. Fu L., Kim Y.A., Wang X., Wu X., Yue P., Lonial S., Khuri F.R., Sun S.Y. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy. Cancer Res 2009, 69:8967-8976.
53. Puissant A., Robert G., Fenouille N., Luciano F., Cassuto J.P., Raynaud S., Auberger P. Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation. Cancer Res 2010, 70:1042-1052.
54. Palamara A.T., Nencioni L., Aquilano K., De Chiara G., Hernandez L., Cozzolino F., Ciriolo M.R., Garaci E. Inhibition of influenza A virus replication by resveratrol. J Infect Dis 2005, 191:1719-1729.
55. Lee H.K., Mattei L.M., Steinberg B.E., Alberts P., Lee Y.H., Chervonsky A., Mizushima N., Grinstein S., Iwasaki A. In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 2010, 32:227-239.
56. Blanchet F.P., Moris A., Nikolic D.S., Lehmann M., Cardinaud S., Stalder R., Garcia E., Dinkins C., Leuba F., Wu L., et al. Human immunodeficiency virus-1 inhibition of immunoamphisomes in dendritic cells impairs early innate and adaptive immune responses. Immunity 2010, 32:654-669.
57. English L., Chemali M., Duron J., Rondeau C., Laplante A., Gingras D., Alexander D., Leib D., Norbury C., Lippe R., et al. Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009, 10:480-487.
58. Uhl M., Kepp O., Jusforgues-Saklani H., Vicencio J.M., Kroemer G., Albert M.L. Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells. Cell Death Differ 2009, 16:991-1005.
59. Jagannath C., Lindsey D.R., Dhandayuthapani S., Xu Y., Hunter R.L., Eissa N.T. Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 2009, 15:267-276.